ARTICLE | Company News
FDA accepts Northera resubmission
July 18, 2013 12:53 AM UTC
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) said FDA accepted for review a resubmitted NDA for Northera droxidopa to treat symptomatic neurogenic orthostatic hypotension (NOH) in patients wi...